Recent news on Epoetin

MIRCERA Receives Positive Opinion in Europe for the Treatment of ...  -  25 May 2007
Juraforum.de,...once monthly as a single intravenous or subcutaneous injectionto maintain target haemoglobin levels for patients currently beingtreated with an ESA (epoetin

CHMP backs Roche's Mircera  -  25 May 2007
Pharma Times (subscription),...while rivals such as Amgen's Epogen (epoetin alfa) and Johnson & Johnson's Procrit (epoetin alfa) can be dosed up to three times a week.

Committee for Medicinal Products for Human Use Summary of Positive ...  -  25 May 2007
PharmaLive.com (press release),The active substance of MIRCERA is methoxy polyethylene glycol-epoetin beta, an antianaemic product (ATC Code B03XA03) that stimulates erythropoiesis by

EU drug panel doesn't back Amgen's Vectibix for colon cancer  -  25 May 2007
MarketWatchMircera (methoxy polyethylene glycol-epoetin beta), from Roche Registration Ltd, for the treatment of anaemia associated with chronic kidney disease.

Aranesp® and Epoetin Alfa Do Not Increase Blood Clots in Ovarian ...  -  May 1, 2007
Cancer Consultants (press release),According to an article recently published in Gynecologic Oncology, use of Aranesp® (darbepoetin alfa) or epoetin alfa (Procrit® or Epogen®) does not appear

FDA issues approvable letter for Roche's Mircera  -  May 21, 2007
Pharma Times (subscription),...of the warning labels on Amgen's ESAs, Aranesp (darbepoetin alfa) and Epogen (epoetin alfa), as well as Johnson & Johnson's Procrit (also epoetin alfa).

Amgen knocked back as EPO competition looms  -  May 17, 2007
BiopharmaReporter.com,Afer a long battle, Shire won approval to sell Dynepo (epoetin delta), its rival anaemia drug, in Europe back in 2004. The company launched the drug,

Amgen shares slide yet again over Medicare coverage cuts  -  May 16, 2007
Pharma Times (subscription),...as well as Johnson & Johnson's Procrit (also epoetin alfa), the Centers for Medicare & Medicaid Services (CMS) has proposed limiting payments for the

Amgen's US monopoly in EPO drugs may be close to its end  -  May 22, 2007
BiopharmaReporter.com,Shire has no plans to enter the US market with its rival product Dynepo (epoetin delta), but observers suggest that Amgen's monopoly on anaemia drugs in the

Amgen and J&J hurt by FDA panel over anaemia drugs  -  May 11, 2007
Pharma Times (subscription),...alfa) and Epogen (epoetin alfa) and J& J's Procrit (also epoetin alfa) be contingent upon adding additional restrictions to the drugs' labels.

Amgen, J&J Defend Anemia Drugs Before US FDA Panel  -  May 10, 2007
Cancerpage.com,The epoetin drugs, which include Amgen's Aranesp and Epogen as well as J&J's Procrit, are the subject of renewed scrutiny by the agency following concerns

CMS Cites EPO's Bad Rap In Plan To Curtail Reimbursement  -  May 15, 2007
BioWorld Online,Amgen, of Thousand Oaks, Calif., makes all the products in question: Aranesp (darbepoetin alfa), Epogen (epoetin alfa) and Procrit (epoetin alfa).

FDA Sounds Alert on Anemia Drugs  -  May 1, 2007
Journal of American Medical Association (subscription),The FDA warning applies specifically to darbepoetin alfa (Aranesp, made by Amgen Inc, Thousand Oaks, Calif) and epoetin alfa (Epogen, made by Amgen,

Roche receives approvable letter for Mircera in the United States  -  May 21, 2007
PressReleaseNetwork.com (press release)It is also the only anaemia therapy to have compared itself in clinical trials against epoetin alfa, beta and darbepoetin alfa.

FDA Panelists Suggest Some Changes To EPO Prescribing  -  May 10, 2007
BioWorld Online,In addition to Aranesp, the products also include Epogen (epoetin alfa) and Johnson & Johnson's Procrit (epoetin alfa). Approved as supportive-care drugs to

Recommendations for Primary Care of the Patient With Cancer  -  Apr 30, 2007
Medscape (subscription)Anemia secondary to chemotherapy should be treated with epoetin alfa (level A). Chemotherapy-induced anemia usually starts several weeks after treatment

Roche's New ESA* Effectively Stabilises Haemoglobin Levels In ...  -  Apr 25, 2007
Medical News Today (press release),New data presented today1 at the World Congress of Nephrology (WCN) shows that once-monthly methoxy polyethylene glycol-epoetin beta effectively stabilises

FDA Panel warns anemia drug dangerous for cancer patients  -  May 14, 2007
News-Medical.net,The drugs which are known generically as darbepoetin and epoetin, are thought to be used by almost a half-million cancer patients a year in the United

New anaemia med warnings  -  May 12, 2007
Health24.com,The drugs include darbepoetin (Aranesp) and epoetin alfa (Epogen and Procrit). They are genetically engineered versions of a natural protein, erythropoietin

Advisers urge restrictions on anemia drugs  -  May 12, 2007
Inland Valley Daily Bulletin,The drugs, known generically as darbepoetin and epoetin, were approved to reduce the need for blood transfusions in patients with anemia from chemotherapy.

FDA panel warns of anemia drug risks  -  May 11, 2007
Science Daily (press release)The New York Times said the drugs, known generically as darbepoetin and epoetin, are used by about a half-million US cancer patients a year.

Doctors paid millions by Amgen and Johnson & Johnson to push ...  -  May 9, 2007
International Herald Tribune,Known generically as epoetin and darbepoetin, and often referred to simply as Epo, the drugs are genetically engineered versions of a human protein that

In Cancer-Related Anemia Researchers Warn Caution In The Use Of ESAs  -  May 7, 2007
Medical News Today (press release),The ESAs darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit) are genetically engineered forms of a protein called erythropoietin,

Discovery Labs Reports First Quarter 2007 Financial Results  -  May 2, 2007
Primenewswire (press release),Mr. Amick enjoyed a highly successful 30-year career with Johnson & Johnson (J&J) where he led the launch of Procrit(r) (Epoetin alfa) and built J&J's

Prospective Model Outlined Potential Time and Cost Savings of Once ...  -  Apr 24, 2007
PharmaLive.com (press release),The primary objective of this analysis was to evaluate time and associated in-center supply costs observed while administering epoetin alfa three times a

Dialysis facility type may affect epoetin therapy  -  Apr 17, 2007
Scientific AmericanNEW YORK (Reuters Health) - The organization status and ownership of a dialysis facility appears to influence the dose of epoetin that patients with anemia

Dialysis Facility Ownership and Epoetin Dosing in Patients ...  -  Apr 17, 2007
Journal of American Medical Association (subscription),Context Epoetin therapy for dialysis-related anemia is the single largest Medicare drug expenditure. The type of facility (profit, chain, and affiliation

Use of Epoetin in Chronic Renal Failure  -  Apr 17, 2007
Journal of American Medical Association (subscription),In this issue of JAMA, Thamer and colleagues 1 examine the use of epoetin in US dialysis facilities. This report comes at an opportune time given the recent

Anemia Treatment Epoetin and For Profit Dialysis  -  Apr 17, 2007
Insider Medicine,Between 1991 and 2005 the use of the drug epoetin, which is used to increase the red blood cell count in hemodialysis patients increased about four-fold.

IV Iron Decreases Epoetin Dose Requirements and Improves ...  -  Apr 13, 2007
Cancer Consultants (press release),Researchers from Sweden have reported that the addition of intravenous (IV) iron improves hemoglobin responses and decreased epoetin beta (NeoRecornan®)

Anemia treatment for patients with kidney disease can differ by ...  -  Apr 18, 2007
News-Medical.net,The drug epoetin can be administered to increase red blood cell count to an appropriate range, and this is measured by hematocrit levels (the percentage of

Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month ...  -  Apr 23, 2007
PharmaLive.com (press release),Similarly, the data in dialysis patients previously treated with three-times weekly Epoetin Alfa demonstrated that mean hemoglobin (Hgb) levels could be

For-profit Dialysis Centres May Be Over-Treating Anemia  -  Apr 18, 2007
Medical News Today,Epoetin (marketed as Epogen and Procrit) is a manmade version of erythropoietin and is prescribed to kidney patients as part of their dialysis treatment,

Ortho Biotech Revises Prescribing Information for PROCRIT(R ...  -  Apr 3, 2007
Drug Newswire (press release),Located in Bridgewater, NJ, Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments

Some Dialysis Centers Overtreat Anemia: Study  -  Apr 17, 2007
Atlanta Journal Constitution (subscription),The typical hospital-based dialysis center administered an average dose of 16188 units per week of epoetin, a drug that helps correct anemia.

‘For-profit Dialysis Centers’ in the Spotlight Over Anti-anemia ...  -  Apr 20, 2007
MedIndia,Epoetin is a drug that acts as a substitute for erythropoietin, and is being prescribed to kidney patients during the course of dialysis.

Controversy Over For-Profit Dialysis Centers  -  Apr 18, 2007
Dog Flu Diet and Diseases,It found that doctors that worked for the for-profit chains were more likely to prescribe bigger doses of an anemia drug called epoetin.

For-profit dialysis more aggressive on anemia drugs  -  Apr 17, 2007
Scientific AmericanEpoetin boosts oxygen-transporting hemoglobin in red blood cells of kidney disease patients, who are prone to low red blood cell counts.

For-Profit Dialysis Centers Bigger Users of Epoietin Per Patient  -  Apr 17, 2007
MedPage Today,In November 2006, European investigators with the Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Beta (CREATE) trial suggested that

For-profit dialysis sites use more drug  -  Apr 17, 2007
United Press InternationalAlthough epoetin was recommended for people with hematocrits of 35 or below with a target of 36, the researchers found that for-profit dialysis centers

MIRCERA(R) Effective in Stabilising Haemoglobin Levels in Elderly ...  -  Apr 23, 2007
PR Newswire Brasil (liberação de imprensa),In these two trials 1245 dialysis patients were randomized to remain on their current epoetin treatment administered up to three times or week or to be

Showtime for Amgen  -  Apr 18, 2007
The Deal Blogs,Aranesp is an epoetin, a red-blood-cell booster given to cancer and renal failure patients with anemia. Aranesp and Epogen, an older similar drug,

Aranesp linked to higher death rate in cancer trial  -  Apr 17, 2007
Pharma Times (subscription),In March, US regulators requested that new safety and dosage information should be added the labels of Amgen's Aranesp and Epogen (epoetin alfa) and Johnson

Dialysis Clinics Over-Treating Anemia For Profit  -  Apr 18, 2007
E Canada Now,...centers set up for profit ended up getting the highest doses of treatment drugs such as epoetin compared to those who went to the non-profit centers.

Affymax cites positive Hematide data  -  Apr 12, 2007
BusinessWeekThe study involved 165 patients who switched from a thrice-weekly treatment with Epoetin Alfa. Amgen Inc. and Johnson & Johnson both sell Epoetin Alfa drugs

Affymax (AFFY) Announces Results From Phase 2 Clinical Trial of ...  -  Apr 12, 2007
StreetInsider.com (subscription),The results from this maintenance-switch trial in patients previously treated with three-times weekly Epoetin Alfa (EPO) demonstrated that mean hemoglobin

Stifel Likes Amgen From a Valuation Standpoint  -  Apr 9, 2007
Seeking Alpha,...in IMS script data through 3/23/ 07 and have downwardly adjusted 1Q07 revenue estimates for most drugs and most significantly for the epoetin franchise.

SHIRE PLC - 1st Quarter Results  -  Apr 25, 2007
PR-Inside.com (Pressemitteilung),Product Highlights DYNEPO® (epoetin delta) - Anemia associated with chronic kidney disease * In March 2007 Shire launched DYNEPO in Germany,

Affymax drug promising for dialysis anemia  -  Apr 12, 2007
United Press InternationalThe company said its open-label, "maintenance-switch" trial showed 165 patients who had been taking Epoetin Alfa three times a week, and switched to monthly

The Top 14 Most Counterfeited Medications  -  Mar 28, 2007
ScienceBlogsEpogen (epoetin alfa - often used in the treatment of those with HIV, receiving chemotherapy, or with renal failure). 5. Lamisil (terbinafine - used in the

Amgen posts strong results after Aranesp relief  -  Apr 24, 2007
BiopharmaReporter.com,Sales of Epogen (epoetin alfa), Amgen's older anaemia drug, increased only 3 per cent to $625m in the quarter - a growth "partially offset by changes in

Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 ...  -  Apr 23, 2007
Genetic Engineering News (press release),Sales of EPOGEN(R) (Epoetin alfa) increased 3 percent to $625 million in the first quarter of 2007 versus $604 million in the first quarter of 2006.

Mircera stabilizes Hb levels in elderly dialysis patients  -  Apr 23, 2007
Renal Business Today,...stable hemoglobin levels in dialysis patients over the age of 65 that were switched from the frequently administered agents epoetin alfa and beta.

Mircera Effective in Stabilising Haemoglobin Levels in Elderly ...  -  Apr 23, 2007
PharmaLive.com (press release),...in dialysis patients over and under 65 years of age who were successfully switched from the frequently administered agents, epoetin alfa and beta.

MIRCERA(R) Effective in Stabilising Haemoglobin Levels in Elderly ...  -  Apr 23, 2007
Juraforum.de,...levels in dialysis patients over andunder 65 years of age who were successfully switched from thefrequently administered agents, epoetin alfa and beta.

Aranesp(R) "145 Study" Shows No Difference In Survival In Patients ...  -  Apr 23, 2007
Medical News Today (press release),A higher incidence of deep venous thrombosis was documented in patients receiving Epoetin alfa who were not receiving prophylactic anticoagulation.

Lawmakers Go After Amgen and J&J Over Off-Label Sales of Anemia Drugs  -  Apr 22, 2007
Lawyers and Settlements,The drugs at issue include Aranesp, the brand name for darbepoetin, and Epogen and Procrit, the brand names for epoetin. Amgen manufactures all three drugs,

Data Analyses Outline Efficacy and Safety of MIRCERA™ for the ...  -  Apr 13, 2007
WebWire (press release),This was an overview of six global studies in approximately 2400 patients that compared MIRCERA with epoetin alfa or beta and with darbepoetin alfa.

Data Analyses Outline Efficacy and Safety of MIRCERA(TM) for the ...  -  Apr 12, 2007
PR Newswire (press release),...once every four weeks in patients with or without congestive heart failure who were on dialysis and were directly converted from epoetin alfa or beta.

DNAPrint(TM) Genomics` Advancements in PT-401 and Statinome ...  -  Apr 5, 2007
MacReport (press release),In one study, PT-401 was shown to be more potent and longer acting than epoetin alfa, a form of recombinant human erythropoietin currently in the market for

New Human Cell-Produced Treatment for Anaemia Associated With ...  -  Mar 28, 2007
Drug Newswire (press release),DYNEPO (epoetin delta) is indicated for the treatment of anaemia in patients with CRF and may be used in patients on dialysis and in patients not on

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional